The role of sense of coherence in reducing anxiety and depressive symptoms among patients at the first acute coronary event: A three-year longitudinal study

Greco, Andrea; Brugnera, Agostino; Adorni, Roberta; Tasca, Giorgio A.; Compare, Angelo; Viganò, Anna; Fattirolli, Francesco; Giannattasio, Cristina; D’Addario, M; Steca, Patrizia

doi:10.1016/j.jpsychores.2022.110974

Cited by 4 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, we will use symptom measures effects to examine shorter durations, enabling the assessment of how moods can influence each other and elicit significant interaction effects within short periods. Anxiety and depression symptoms tend to stabilise over time, and interactions between them in terms of predicting recurrent cardiac events are moderated by symptoms of depression, and these might manifest in patients with acute cardiac diseases within 6 months 32 33. The data for primary outcomes at baseline (T0) will be collected between November 2023 and February 2024, patients will then be assessed at 1 (T1), 3 (T2) and 6 (T3) months of follow-up.…”

Section: Methodsmentioning

confidence: 99%

Depression and anxiety symptom network structure among patients with coronary heart disease and association with quality of life: protocol for a multicentre cross-sectional and prospective longitudinal study

He,

Wang,

et al. 2024

BMJ Open

View full text Add to dashboard Cite

BackgroundAnxiety and depression are critical mental health problems among persons with coronary heart disease (CHD). The range of symptoms is an important stressor for adverse cardiovascular events, and these symptoms can be involved in various ways during the course of CHD. However, the characteristics and mechanisms of comorbidity between the two mental states from the viewpoint of symptom interactions in patients with CHD remain unclear. Therefore, we aim to apply a symptom-oriented approach to identify core and bridge symptoms between anxiety and depression in a population with CHD and to identify differences in network structure over time and symptomatic link profiles.Methods and analysisWe designed a multicentre, cross-sectional, longitudinal study of anxiety and depression symptoms among patients with CHD. We will evaluate degrees of symptoms using the Generalized Anxiety Disorder Scale, the Patient Health Questionnaire and the WHO Quality of Life-Brief version. Patients will be followed up for 1, 3 and 6 months after baseline measurements. We will analyse and interpret network structures using R software and its packages. The primary outcomes of interest will include centrality, bridge connections, estimates, differences in network structures and profiles of changes over time. The secondary outcome measures will be the stability and accuracy of the network. By combining cross-sectional and longitudinal analyses, this study should elucidate the central and potential causative pathways among anxiety and depression symptom networks as well as their temporal stability in patients with CHD.Ethics and disseminationThe project conforms to the ethical principles enshrined in the Declaration of Helsinki (2013 amendment) and all local ethical guidelines. The ethics committee at the University of South China approved the study (Approval ID: 2023-USC-HL-414). The findings will be published and presented at conferences for widespread dissemination.Trial registration numberChiCTR2300075813.

show abstract

Section: Methodsmentioning

confidence: 99%